Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30

$29.54−1.08 (-3.53%)

Close on Nov 13, 2026Market cap $1.16BP/E –Yield –

Alto Neuroscience operating margin

Operating margin is operating income as a percentage of revenue.

Alto Neuroscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?